Prediction of Recurrence by Machine Learning in Salivary Gland Cancer Patients After Adjuvant (Chemo)Radiotherapy

In Vivo. 2021 Nov-Dec;35(6):3355-3360. doi: 10.21873/invivo.12633.

Abstract

Background/aim: To investigate survival outcomes and recurrence patterns using machine learning in patients with salivary gland malignant tumor (SGMT) undergoing adjuvant chemoradiotherapy (CRT).

Patients and methods: Consecutive SGMT patients were identified, and a data set included nine predictor variables and a dependent variable [disease-free survival (DFS) event] was standardized. The open-source R software was used. Survival outcomes were estimated by the Kaplan-Meier method. The random forest approach was used to select the important explanatory variables. A classification tree that optimally partitioned SGMT patients with different DFS rates was built.

Results: In total, 54 SGMT patients were included in the final analysis. Five-year DFS was 62.1%. The top two important variables identified were pathologic node (pN) and pathologic tumor (pT). Based on these explanatory variables, patients were partitioned in three groups, including pN0, pT1-2 pN+ and pT3-4 pN+ with 26%, 38% and 75% probability of recurrence, respectively. Accordingly, 5-year DFS rates were 73.7%, 57.1% and 34.3%, respectively.

Conclusion: The proposed decision tree algorithm is an appropriate tool to partition SGMT patients. It can guide decision-making and future research in the SGMT field.

Keywords: DFS; Machine learning; artificial intelligence; classification tree; decision tree; disease-free survival; recurrence; salivary gland cancer; tumor.

MeSH terms

  • Chemoradiotherapy
  • Chemoradiotherapy, Adjuvant
  • Disease-Free Survival
  • Humans
  • Machine Learning
  • Neoplasm Recurrence, Local*
  • Retrospective Studies
  • Salivary Gland Neoplasms* / therapy